Answers are grounded in this paper and cite their sources.
// Chao Han 1, 2 , Nicole A. Seebacher 2 , Francis J. Hornicek 2 , Quancheng Kan 1 and Zhenfeng Duan 1, 2 1 Department of Pharmacy, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, P.R. China 2 Sarcoma Biology Laboratory, Center for Sarcoma and Connective Tissue Oncology, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA Correspondence to: Quancheng Kan, email: quanchengkan@yeah.net Zhenfeng Duan, email: zduan@mgh.harvard.edu Keywords: circRNA, miRNA, cancer, gene regulatory mechanisms, target therapy Received: May 25, 2017 Accepted: July 25, 2017 Published: August 04, 2017 ABSTRACT Circular RNAs (circRNAs) are a newly validated class of endogenous non-coding RNA, generated from the ligation of exons, introns, or both, which arise via a diverse number of cellular mechanisms. Due to rapid advances in the development of combined high-throughput sequencing and bioinformatics analyzing tools, many circRNAs have recently been discovered, revealing an expansive number of ubiquitously expressed mammalian circRNAs. Interestingly, it has recently been confirmed that circRNAs bind to microRNAs (miRs), as miR “sponges”, acting to suppress miR function. As miRs are known to alter the development and progression of cancer, circRNAs may offer a novel diagnostic and prognostic biomarker for cancer. Indeed, recent evidence has shown that circRNAs are associated with many human cancers. Herein, we review the molecular characteristics and biogenesis of circRNAs, with a focus on newly identified circRNAs that may play an important role in human cancer, through their regulation of miR expression.
No takes yet. Share an insight, caveat, or question.
Han et al. (2017) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: